Cargando…
Dialyzer clearance of myoglobin with middle molecule filter and low blood flow CVVHD in patients with rhabdomyolysis-associated acute kidney injury
Autores principales: | Leppanen, I, Ahonen, T, Tenhunen, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642894/ http://dx.doi.org/10.1186/cc12370 |
Ejemplares similares
-
Super high-flux CVVHD using regional citrate anticoagulation: long-term stability of middle molecule clearance
por: Siebeck, M, et al.
Publicado: (2015) -
Extracorporeal therapies in acute rhabdomyolysis and myoglobin clearance
por: Ronco, Claudio
Publicado: (2005) -
The correlation between creatine kinase and myoglobin in critical ill patients with rhabdomyolysis
por: Mikkelsen, TS, et al.
Publicado: (2004) -
The pharmacokinetics of tigecycline in critically ill adult patients undergoing CVVHD
por: Rypulak, E, et al.
Publicado: (2015) -
Citrate anticoagulation realized as CVVHD using a newly designed dialysate solution
por: Morgera, S, et al.
Publicado: (2006)